Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Better LDL Control After STEMI Means Less Neoatherosclerosis

News Daily News

Better LDL Control After STEMI Means Less Neoatherosclerosis

Yael L. Maxwell

December 23, 2025

TCTMD’s Top 10 Most Popular Stories for November 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

December 01, 2025

November 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

November 24, 2025

August 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

August 22, 2025

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

July 15, 2025

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

July 11, 2023

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

February 26, 2019

News Industry News

Symic Biomedical Selects Vascular Clinical Candidate

July 20, 2015

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

October 23, 2013

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

March 07, 2012

News Daily News

Meta-Análisis: Cilostazol Adyuvante Reduce la Necesidad de Volver a Revascularizar tras una PCI

March 07, 2012

Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI

Presentation

Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI

Presenter: S. Friedland

March 06, 2012

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.